Home・Stock List・Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corp

Open

SectorHealthcare

18.17 5.09

Buy Sell

Overview

Share price change

24h

Current

Min

17.14

Max

18.61

Key metrics
By Trading Economics
Income	9.2M 4.6M
Sales	27M 419M
EPS	0.56
Profit margin	1.103
Employees	4,427
EBITDA	-35M 28M

Recommendations
By TipRanks
Recommendations	Neutral
12 Months Forecast	+10.99% upside

Dividends
By Acuity
Next Earnings	29 Oct 2026

Market Stats
By TradingEconomics
Market Cap	-192M 1.3B
Previous open	13.08
Previous close	18.17

News Sentiment

By Acuity

25%

75%

54 / 340 Healthcare

Integra LifeSciences Holdings Corp Chart

Past performance is not a reliable indicator of future results.

Related News

12 Aug 2026, 23:31 UTC

Integra Lifesciences Holdings Corp shares are higher in after-market trading, buoyed by easing inflation concerns and broader market trends. No specific news was identified.

10 Aug 2026, 20:06 UTC

Integra Lifesciences Holdings Corp shares are lower today, following a volatile session that included an initial gain before declining to a session low.

7 Aug 2026, 19:16 UTC

News

Integra Lifesciences reported flat revenue of $418.8 million and adjusted EPS of $0.56, exceeding expectations. Shares are advancing in response to the earnings results.

6 Aug 2026, 19:36 UTC

Integra Lifesciences Holdings Corp shares are lower today, continuing a decline since Wednesday's close. The stock remains below its 20-day moving average.

5 Aug 2026, 19:36 UTC

Integra Lifesciences Holdings Corp shares are lower today, continuing a decline since Tuesday's close. The stock remains significantly below its 20-day moving average.

4 Aug 2026, 19:46 UTC

Integra Lifesciences Holdings Corp shares are lower during Tuesday's session, approximately 3.60% below the 20-day moving average, with no specific news identified.

3 Aug 2026, 20:51 UTC

Integra Lifesciences Holdings Corp gains in after-market hours, reflecting broader market optimism despite no specific company news. Major indices also show significant increases.

31 Jul 2026, 19:46 UTC

Integra Lifesciences Holdings Corp shares are lower during Friday's session, trading near the lower end of their one-month range with no specific news identified.

30 Jul 2026, 17:41 UTC

Integra Lifesciences Holdings Corp shares are higher today, despite earlier session pullbacks. No specific news was identified to explain the movement.

29 Jul 2026, 21:01 UTC

Integra Lifesciences shares are lower in after-market hours, reflecting a broader decline in U.S. equities amid rising oil prices and geopolitical tensions.

28 Jul 2026, 20:03 UTC

News

Shares of Integra Lifesciences Holdings are higher, supported by UBS's Neutral rating and price target of $19 amid broader Health Care Equipment gains.

27 Jul 2026, 19:51 UTC

Integra Lifesciences Holdings Corp shares are lower today amid notable volatility, despite remaining near the upper end of their one-month trading range.

24 Jul 2026, 19:02 UTC

News

Integra Lifesciences shares are higher today, following a downgrade from Wall Street Zen and a price target increase from Truist Financial to $19.00.

21 Jul 2026, 18:46 UTC

Integra Lifesciences Holdings shares are higher amid broader market recovery, despite a slight pullback from earlier gains. The stock remains above its 20-day moving average.

20 Jul 2026, 19:26 UTC

News

Integra Lifesciences Holdings is lower amid broader market pressure from rising Treasury yields. Investors await upcoming quarterly results after exceeding earnings expectations.

Peer Comparison

Price change

Integra LifeSciences Holdings Corp Forecast

Price Target

By TipRanks

10.99% upside

12 Months Forecast

Average 19.29 USD 10.99%

High 25 USD

Low 17 USD

Based on 9 Wall Street analysts offering 12 month price targets forIntegra LifeSciences Holdings Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

9 ratings

Buy

Hold

Sell

Based on 9 analysts giving stock ratings to Integra LifeSciences Holdings Corp - Dist in the past 3 months.

Sentiment

By Acuity

54 / 340 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.